Moderna (MEX:MRNA) Accounts Payable : MXN4,624 Mil (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Accounts Payable?

Moderna's Accounts Payable for the quarter that ended in Mar. 2025 was MXN4,624 Mil.

Moderna's quarterly Accounts Payable increased from Sep. 2024 (MXN7,344 Mil) to Dec. 2024 (MXN8,447 Mil) but then declined from Dec. 2024 (MXN8,447 Mil) to Mar. 2025 (MXN4,624 Mil).

Moderna's annual Accounts Payable declined from Dec. 2022 (MXN9,495 Mil) to Dec. 2023 (MXN8,827 Mil) and declined from Dec. 2023 (MXN8,827 Mil) to Dec. 2024 (MXN8,447 Mil).

Moderna Accounts Payable Historical Data

The historical data trend for Moderna's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Accounts Payable Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

358.06

6,195.23

9,494.55

8,826.61

8,446.56

Moderna Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															3,037.12	5,111.31	7,344.48	8,446.56	4,623.55

Moderna Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Moderna Accounts Payable Related Terms

Thank you for viewing the detailed overview of Moderna's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

MRNA:USA 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

325 Binney Street, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.